Delivery Order SPE2DB20D2014-SPE2DB25FD09E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,884.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $16,157.58 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on November 5, 2025. This firm fixed-price delivery order, which was not set-aside and competitively awarded, is due for completion by November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) with a ceiling value of $2,137.02. This non-competitive delivery order, awarded on September 3, 2025, represents a firm fixed-price transaction with an ultimate completion date of September 4, 2025. The contractor will fulfill this order from its facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units) valued at $2,602.25. This firm fixed price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 10, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $11,215.32 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (quantity: 3 units). This firm fixed-price delivery order, valued at $10,191.60, represents a non-competitive award under an existing contract vehicle and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. The order falls...
- The Defense Logistics Agency awarded a delivery order valued at $8,043.36 to AmerisourceBergen Drug Corp on August 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count package). This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for completion by August 26, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $3,926.06 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) on October 24, 2025, with completion targeted for October 27, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to support federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this...
- The Defense Logistics Agency awarded a delivery order valued at $3,097.58 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (three-unit supply) on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $3,145.59 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3). This contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement needs,...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD09EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,860.10 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed price, non-competitive delivery order was issued on September 24, 2025, with an ultimate completion date of September 25, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs, the Defense Health Agency, and other government healthcare systems worldwide. The company was selected through competitive processes for this prime contract vehicle, which enables flexible fulfillment of pharmaceutical requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/24/25 |